chr17-41583872-A-G
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PS1_ModeratePM1PM2PP3_ModeratePP5_Very_Strong
The NM_000526.5(KRT14):c.815T>C(p.Met272Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin UniProt.
Frequency
Consequence
NM_000526.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KRT14 | NM_000526.5 | c.815T>C | p.Met272Thr | missense_variant | 4/8 | ENST00000167586.7 | NP_000517.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KRT14 | ENST00000167586.7 | c.815T>C | p.Met272Thr | missense_variant | 4/8 | 1 | NM_000526.5 | ENSP00000167586.6 | ||
KRT14 | ENST00000476662.1 | n.265T>C | non_coding_transcript_exon_variant | 2/4 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2Other:1
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2024 | KRT14: PM1, PM2, PM5, PP1:Moderate, PS4:Moderate - |
not provided, no classification provided | literature only | Epithelial Biology; Institute of Medical Biology, Singapore | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 22, 2016 | The M272T pathogenic variant in the KRT14 gene has been reported previously in association with EBS. It is found in the linker L12 region where variants usually result in milder forms of EBS. The M272T variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The M272T variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants at the same residue ( M272R) and in nearby residues (V268D, V270M,A, V273G, D273G, A274D) have been reported in the Human Gene Mutation Database in association with EBS (Stenson et al., 2014), supporting the functional importance of this region of the protein. We interpret M272T as a pathogenic variant. - |
Epidermolysis bullosa simplex Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Molecular Genetics, Royal Melbourne Hospital | May 05, 2023 | This sequence change in KRT14 is predicted to replace methionine with threonine at codon 272, p.(Met272Thr). The methionine residue is moderately conserved (100 vertebrates, UCSC), and is located in the L12 rod domain. There is a moderate physicochemical difference between methionine and threonine. This variant is absent from the population database gnomAD v2.1 and v3.1. This variant has been reported in at least seven probands with an immunohistochemical diagnosis of epidermolysis bullosa simplex (EBS) and as a de novo occurrence with unconfirmed parental relationships in one individual with EBS (PMID: 16786515, 20199538, 26432462, 29242947). Computational evidence predicts a deleterious effect for the missense substitution (REVEL = 0.877). Another missense variant c.815T>G, p.(Met272Arg) in the same codon with similar physicochemical properties to the variant under assessment has been classified as likely pathogenic for EBS (PMID: 7682883, 21375516). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.6.1, this variant is classified as PATHOGENIC. Following criteria are met: PS4, PM5, PM6, PM2_Supporting, PP3. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at